These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 36449423)

  • 1. Bismuth Subsalicylate Poisoning.
    Meaden CW; Calello DP
    N Engl J Med; 2022 Dec; 387(22):2074. PubMed ID: 36449423
    [No Abstract]   [Full Text] [Related]  

  • 2. Fatal salicylate toxicity from bismuth subsalicylate.
    Sainsbury SJ
    West J Med; 1991 Dec; 155(6):637-9. PubMed ID: 1812638
    [No Abstract]   [Full Text] [Related]  

  • 3. Aspirin and bismuth subsalicylate.
    Levy G
    Am J Dis Child; 1993 Dec; 147(12):1281. PubMed ID: 8249944
    [No Abstract]   [Full Text] [Related]  

  • 4. Chronic salicylate toxicity due to consumption of over-the-counter bismuth subsalicylate.
    Vernace MA; Bellucci AG; Wilkes BM
    Am J Med; 1994 Sep; 97(3):308-9. PubMed ID: 8092182
    [No Abstract]   [Full Text] [Related]  

  • 5. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy.
    Mendelowitz PC; Hoffman RS; Weber S
    Ann Intern Med; 1990 Jan; 112(2):140-1. PubMed ID: 2294817
    [No Abstract]   [Full Text] [Related]  

  • 6. Bismuth Subsalicylate Coagulopathy in a Patient with Chronic Liver Disease.
    Yu C; Eustaquio N; Calello DP; Ruck BE; Nelson LS; Santos C
    J Med Toxicol; 2019 Jul; 15(3):198-201. PubMed ID: 31062178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photo quiz. Pepto Bismol poisoning.
    Hearney EG; Fuhrer J; Marioz P
    Clin Infect Dis; 1996 Jul; 23(1):37,159. PubMed ID: 8816125
    [No Abstract]   [Full Text] [Related]  

  • 8. Case 1: Mysteriously Rising Salicylate Levels in a 15-year-old Girl.
    Parker V; Goldberg D; King MA
    Pediatr Rev; 2017 Jun; 38(6):280-281. PubMed ID: 28572137
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible toxicity in poisoning with colloidal bismuth subcitrate.
    Hudson M; Mowat NA
    BMJ; 1989 Jul; 299(6692):159. PubMed ID: 2504358
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of subsalicylate bismuth on absorption of doxycycline.
    Ericsson CD; Feldman S; Pickering LK; Cleary TG
    JAMA; 1982 Apr; 247(16):2266-7. PubMed ID: 7040708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of early syphilis with penicillin and bismuth subsalicylate; daily injection of 500,000 units of penicillin G in sodium chloride solution for 20 consecutive days and 10 to 20 doses of bismuth subsalicylate at the rate of two a week.
    PARDO-CASTELLO V; PARDO OA
    Arch Derm Syphilol; 1950 Feb; 61(2):196-209. PubMed ID: 15403965
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of early syphilis with penicillin and bismuth subsalicylate: daily injection of 500,000 units of penicillin G in sodium chloride solution for twenty consecutive days and ten to twenty doses of bismuth subsalicylate at the rate of two a week; second report.
    PARDO-CASTELLO V; PARDO OA
    Am J Syph Gonorrhea Vener Dis; 1950 Sep; 34(5):431-5. PubMed ID: 14771372
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative efficacy of loperamide hydrochloride and bismuth subsalicylate in the management of acute diarrhea.
    DuPont HL; Flores Sanchez J; Ericsson CD; Mendiola Gomez J; DuPont MW; Cruz Luna A; Mathewson JJ
    Am J Med; 1990 Jun; 88(6A):15S-19S. PubMed ID: 2192553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tetracycline bioavailability caused by magnesium aluminum silicate in liquid formulations of bismuth subsalicylate.
    Healy DP; Dansereau RJ; Dunn AB; Clendening CE; Mounts AW; Deepe GS
    Ann Pharmacother; 1997 Dec; 31(12):1460-4. PubMed ID: 9416381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.
    Suarez FL; Furne JK; Springfield J; Levitt MD
    Gastroenterology; 1998 May; 114(5):923-9. PubMed ID: 9558280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of bismuth subsalicylate in relieving symptoms of indigestion.
    Hailey FJ; Newsom JH
    Arch Intern Med; 1984 Feb; 144(2):269-72. PubMed ID: 6365007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of diarrhea caused by enterotoxigenic Escherichia coli: lessons learned with volunteers.
    Graham DY; Evans DG
    Rev Infect Dis; 1990; 12 Suppl 1():S68-72. PubMed ID: 2406859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori.
    Wagner S; Gebel M; Haruma K; Bär W; Lange P; Freise J; Gladziwa U; Schmidt FW
    Gut; 1992 Feb; 33(2):179-83. PubMed ID: 1347278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of bismuth subsalicylate and placebo in the prevention and treatment of enterotoxigenic Escherichia coli-induced diarrhea in volunteers.
    Graham DY; Estes MK; Gentry LO
    Gastroenterology; 1983 Nov; 85(5):1017-22. PubMed ID: 6352386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study.
    Koulinska I; Riester K; Chalkias S; Edwards MR
    Clin Ther; 2018 Dec; 40(12):2021-2030.e1. PubMed ID: 30447891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.